Regional differences in carbapenem-resistant Klebsiella pneumoniae

Affiliations

¹ Department of Infectious Diseases, Monash University, Melbourne, VIC 3004, Australia.
² Department of Infectious Diseases, Monash University, Melbourne, VIC 3004, Australia; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: kat.holt@lshtm.ac.uk.

Comment

Kelly Wyres et al. Lancet Infect Dis. 2022 Mar.

. 2022 Mar;22(3):309-310.

doi: 10.1016/S1473-3099(21)00425-4. Epub 2021 Nov 9.

¹ Department of Infectious Diseases, Monash University, Melbourne, VIC 3004, Australia.
² Department of Infectious Diseases, Monash University, Melbourne, VIC 3004, Australia; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: kat.holt@lshtm.ac.uk.

No abstract available

Conflict of interest statement

We declare no competing interests.

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Wang M, Earley M, Chen L, Hanson BM, Yu Y, Liu Z, Salcedo S, Cober E, Li L, Kanj SS, Gao H, Munita JM, Ordoñez K, Weston G, Satlin MJ, Valderrama-Beltrán SL, Marimuthu K, Stryjewski ME, Komarow L, Luterbach C, Marshall SH, Rudin SD, Manca C, Paterson DL, Reyes J, Villegas MV, Evans S, Hill C, Arias R, Baum K, Fries BC, Doi Y, Patel R, Kreiswirth BN, Bonomo RA, Chambers HF, Fowler VG Jr, Arias CA, van Duin D; Multi-Drug Resistant Organism Network Investigators. Wang M, et al. Lancet Infect Dis. 2022 Mar;22(3):401-412. doi: 10.1016/S1473-3099(21)00399-6. Epub 2021 Nov 9. Lancet Infect Dis. 2022. PMID: 34767753 Free PMC article.